Security key
761330109
Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC)
CUSIP: 761330109
Q1 2016 13F Holders as of 31 Mar 2016
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 27,202,736
- Total 13F value
- $474,936,380
- Share change
- +16,626
- Put/Call ratio
- 183%
- SEC-reported price per share
- $17.46
- Number of holders
- 83
- Value change
- -$25,989,904
- Number of buys
- 47
- Number of sells
- 43
- Shares outstanding
- 104,661,494
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2016
Institutions
83
Top holders
0
RVNC full security history
Ownership snapshot
Newer quarter: Q2 2016
Previous quarter: Q4 2015
Revance Therapeutics, Inc. SEC filings
Revance Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 761330109
Recent filing periods:
Ownership snapshot
Top reported holders of RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
—
Disclosed value leader
—
Comparable rows
0/0
Latest evidence
—
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Archived quarter
Historical 13F summary for Q1 2016
This older quarter remains available as an indexed ownership summary. Detailed holder rows are no longer kept in the hot table for this period.